An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics
- PMID: 27658511
- DOI: 10.2174/1871527315666160920160512
An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics
Abstract
Parkinson's disease (PD) is a devastating and progressive movement disorder characterized by symptoms of muscles rigidity, tremor, postural instability and slow physical movements. Biochemically, PD is characterized by lack of dopamine production and its action due to loss of dopaminergic neurons and neuropathologically by the presence of intracytoplasmic inclusions known as Lewy bodies, which mainly consist of presynaptic neuronal protein, α-synuclein (α-syn). It is believed that alteration in α-syn homeostasis leads to increased accumulation and aggregation of α-syn in Lewy body. Based on the important role of α-syn from pathogenesis to therapeutics, the recent researches are mainly focused on deciphering the critical role of α-syn at advanced level. Being a major protein in Lewy body that has a key role in pathogenesis of PD, several model systems including immortalized cell lines (SH-SY5Y), primary neuronal cultures, yeast (saccharomyces cerevisiae), drosophila (fruit flies), nematodes (Caenorhabditis elegans) and rodents are being employed to understand the PD pathogenesis and treatment. In order to study the etiopathogensis and develop novel therapeutic target for α -syn aggregation, majority of investigators rely on toxin (rotenone, 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine, 6-hydroxydopamine, paraquat)-induced animal models of PD as a tool for basic research. Whereas, cell and tissue based models are mostly utilized to elucidate the mechanistic and molecular pathways underlying the α -syn induced toxicity and therapeutic approaches in PD. Gene modified mouse models based on α-syn expression are fascinating for modeling familial PD and toxin induced models provide a suitable approach for sporadic PD. The purpose of this review is to provide a summary and a critical review of the involvement of α-syn in various in vitro and in vivo models of PD based on use of neurotoxins as well as genetic modifications.
Similar articles
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.J Neurochem. 2016 May;137(3):331-59. doi: 10.1111/jnc.13570. Epub 2016 Mar 23. J Neurochem. 2016. PMID: 26852372 Free PMC article. Review.
-
The role of age-associated alpha-synuclein aggregation in a conditional transgenic mouse model of Parkinson's disease: Implications for Lewy body formation.J Neurochem. 2024 Jul;168(7):1215-1236. doi: 10.1111/jnc.16122. Epub 2024 May 1. J Neurochem. 2024. PMID: 38693066
-
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. doi: 10.1073/pnas.1913904117. Epub 2020 Feb 19. Proc Natl Acad Sci U S A. 2020. PMID: 32075919 Free PMC article.
-
Targeting alpha-synuclein for the treatment of Parkinson's disease.CNS Neurol Disord Drug Targets. 2012 Mar;11(2):174-9. doi: 10.2174/187152712800269678. CNS Neurol Disord Drug Targets. 2012. PMID: 22483285 Review.
Cited by
-
Minimotifs dysfunction is pervasive in neurodegenerative disorders.Alzheimers Dement (N Y). 2018 Jul 25;4:414-432. doi: 10.1016/j.trci.2018.06.005. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30225339 Free PMC article.
-
(E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) Phenol Ameliorates MPTP-Induced Dopaminergic Neurodegeneration by Inhibiting the STAT3 Pathway.Int J Mol Sci. 2019 May 29;20(11):2632. doi: 10.3390/ijms20112632. Int J Mol Sci. 2019. PMID: 31146332 Free PMC article.
-
Alpha-synuclein aggregation, Ubiquitin proteasome system impairment, and L-Dopa response in zinc-induced Parkinsonism: resemblance to sporadic Parkinson's disease.Mol Cell Biochem. 2018 Jul;444(1-2):149-160. doi: 10.1007/s11010-017-3239-y. Epub 2017 Dec 2. Mol Cell Biochem. 2018. PMID: 29198021
-
Modulation of α-Synuclein Fibrillation and Toxicity by 4-Phenylbutyric Acid.ACS Chem Neurosci. 2025 Mar 19;16(6):1066-1078. doi: 10.1021/acschemneuro.4c00709. Epub 2025 Feb 28. ACS Chem Neurosci. 2025. PMID: 40020199 Free PMC article.
-
Animal models of α-synucleinopathy for Parkinson disease drug development.Nat Rev Neurosci. 2017 Sep;18(9):515-529. doi: 10.1038/nrn.2017.75. Epub 2017 Jul 13. Nat Rev Neurosci. 2017. PMID: 28747776 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous